1,3-Dihydro-2H-imidazo[4,5-b]pyrazin-2-one, 95.0%, 250mg

N,N'-Di(4-biphenylyl)-N,N'-diphenylbenzidine>98.0%(HPLC)(N)1g

(R)-3-(Trifluoromethyl)pyrrolidin-3-ol, 98%, 100mg

GC capillary column ROTI®Cap-FFAP, 10 m, 0.10 mm, 0.10 µm, 1 Piece(s)

Tansy oil, pure, 5 ml, glass packaging

2,3-Dimethylpyrido[3,4-b]pyrazin-5(6H)-one, 97.0%, 100mg

2-Cyclohexyl-2-hydroxyacetonitrile, 95%, 1g

Ethyl 2-[3-(1H-indol-2-yl)phenyl]-4-methyl-1,3-thiazole-5-carboxylate, 1g

Z-(3R)-1,2,3,4-Tetrahydroisoquinolene-3-carboxylic acid, 98.0%, 1g

Cis-piperidine-2,3-dicarboxylic acid, 98%, 1g

5-(2-Phenyleth-1-ynyl)nicotinic acid, 5g

N-(3-Bromobenzyl)piperidine-4-amine dihydrochloride, 95.0%, 1g

3,5-Dibromo-1H-1,2,4-triazole, 97.0%, 1g